LifeStance Health Group Inc. Common Stock vs Invesco S&P 500 Momentum ETF — how do they compare? LifeStance Health Group Inc. Common Stock trades at $12.42 (market cap $4.58B), while Invesco S&P 500 Momentum ETF trades at $151.16 (market cap $23.48B). The key difference: Invesco S&P 500 Momentum ETF is far larger — about 5.1× LifeStance Health Group Inc. Common Stock's market cap, and LifeStance Health Group Inc. Common Stock is more actively traded (2,356,698 versus 1,876,152). Which is the better fit depends on your goals — on Pluang, investors hold LifeStance Health Group Inc. Common Stock for 1 Days and Invesco S&P 500 Momentum ETF for 54 Days on average.
| LFST | SPMO | |
|---|---|---|
Market Cap | $4.58B | $23.48B |
Volume | 2,356,698 | 1,876,152 |
Sector | Health | Broad Market / Factor |
52-Week High | $13.38 | $161.66 |
52-Week Low | $4.81 | $107.84 |
Typical Hold Time | 1 Days | 54 Days |
Enterprise Value | $4.82B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPMO trades at $150.84, down 1.41% today, with a neutral technical signal overall. The ETF recently completed its semi-annual reconstitution with 54 substitutions, intensifying its focus on momentum stocks like Apple and Merck while removing Nvidia. Institutional interest remains strong with Envestnet Asset Management increasing its stake by 9.5% in Q2 2026.
SPMO's momentum strategy has historically outperformed the S&P 500 by significant margins, though recent underperformance highlights concentration risks in tech and energy sectors. The fund offers concentrated exposure to top-performing S&P 500 names but faces higher volatility than broader market ETFs.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.
Read more on LFST →SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →